.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In September 2026, Green Mantis Labs’ mix was concentrated entirely in Tincture & Sublingual at 100.0% share, with average price at $39.11 and month-over-month sales down 15.27%; within the New York Tincture & Sublingual context the brand held rank 11. The absence of a reported year-over-year percentage combined with a single-category footprint and an 11th-place rank indicates reliance on one format while conceding higher positions to multi-format peers, implying that category concentration is limiting rank mobility versus a field where share shifts of even a few percentage points can move placements by 2–3 spots.
The 15.27% month-over-month decline alongside 100.0% category dependence means short-term category softness directly compresses overall performance, and a rank of 11 in New York suggests the brand is within striking distance of the top 10 if it can convert even a low-single-digit share gain or mitigate intra-category volatility by 3–5 percentage points. Practically, this positioning implies that expanding into an adjacent dosage or sub-format within Tincture & Sublingual to stabilize month-over-month swings, or selectively piloting a second category to diversify the 100.0% exposure, could translate a 15.27% monthly drawdown into a ranked improvement of 1–2 places during periods when rivals register flatter 0–2% moves.
Competitive Landscape
Green Mantis Labs sits at rank #11 in NY Tincture & Sublingual for September 2026, a 1-spot improvement from #12 in June 2026, but 2 spots behind its peak of #9 in July 2026; without a reported year-over-year rank, the near-term move of +1 rank contrasts with Ayrloom holding #1 with an 8.28% YoY sales gain and Head & Heal fixed at #2 despite a -28.07% YoY decline. The category’s top three also rotated as Veterans Choice Creations (VCC) advanced from #4 YoY to #3 while Mfny (Marijuana Farms New York) slipped from #3 YoY to #4 with -26.53% YoY sales, indicating share is available from declining incumbents; Green Mantis Labs’ small three-month climb (+1) coupled with a 2-rank gap from its July 2026 peak suggests a narrow window to convert competitor contraction into a return to top-10 position rather than a sustained upward break.
Notable Products
CBN/THC 1:2 Sleep Blueberry Tincture (300mg CBN, 600mg THC) posted the largest move in September 2026 with +106% month over month and a climb into rank 3, while the leading CBD/THC 1:1 Citrus Tincture (1000mg CBD, 1000mg THC) fell -16% and held rank 1. Watermelon Tincture (1000mg THC, 60ml) dropped -27% to rank 2 alongside the category shift where all top-4 products are Tincture & Sublingual SKUs, concentrating demand in a single format and tilting toward sleep-focused CBN blends. The SKU mix implies Green Mantis Labs is pivoting from high-volume balanced and THC-only tinctures toward sleep formulations, trading dollar scale today ($8,584 on the leading SKU) for faster-growing niche demand that could reshape the ranking stack next quarter.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
